Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis

Figure 1 Algorithm for the assessment and management of cardiovascular risk in patients with non-alcoholic fatty liver disease. NAFLD: Non-alcoholic fatty liver disease; CVD: Cardiovascular disease; BMI: Body mass index; IMT: Intima-media thickness; FMD: Brachial artery flow-mediated dilation; CVR: Cardiovascular risk; ECG: Electrocardiogram.

Figure 2 Possible pathophysiological mechanisms linking non-alcoholic fatty liver disease/non-alcoholic steatohepatitis to cardiovascular disease. PAD: Peripheral artery disease; OSAS: Obstructive sleep apnoea syndrome; NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; CVD: Cardiovascular disease; ROS: Reactive oxidant species; LDL: Low density lipoprotein.